Skip to content
Mirum Pharmaceuticals Inc icon

Mirum Pharmaceuticals Inc

MIRMStocksPharmaceuticals MajorUnited StatesNasdaqUSD

Price

$89.40

Today

+0.0%

YTD

+13.3%

About

Mirum Pharmaceuticals Inc is a biopharmaceutical company aimed at the development and commercialisation of novel therapies for debilitating liver diseases. The company works on a global scale, principally in the US and Europe. Operating in the healthcare sector, Mirum Pharmaceuticals Inc offers a broad spectrum of services and advancements. The company is focused on rare paediatric diseases and is particularly known for its work on cholestatic liver diseases. Although independent, Mirum Pharmaceuticals Inc collaborates with other organisations to further its research and bring new treatments to market. Track the MIRM share price on your eToro watchlist.

Price chart
Closing price history for MIRM (1D candles).
Open positions
Current open positions for this instrument from your live portfolio.

Open positions

0

Unrealized return

+0.0%

No open positions exist for this instrument at the moment.

Financial insights

Valuation

P/E (TTM)-8.98
P/S (TTM)12.62
P/B (TTM)30.68
Market cap$7.45B
Cap tierMid-cap
Industry avg P/E-43.32

Profitability

Gross margin81.32%
EBIT margin-12.31%
Net margin-494.21%
ROE-335.82%
ROA-101.04%

Earnings & Revenue

Revenue (TTM)$569.61M
Revenue growth (1Y)+50.2%
EPS (TTM)-$13.60
Free cash flow$-172.55M
Total debt$323.78M

Dividends & Risk

Dividend rate$0.00
Dividend yield0.00%
Beta (5Y)0.83
Employees372
Next earnings4 Nov '26
Trade history

Closed trades

0

Realized return

+0.0%

No stored closed trades exist for this instrument yet.

Mirum Pharmaceuticals Inc (MIRM) | Dirk Kuyken